P2Y12 Inhibitor Monotherapy Versus Extended DAPT in Patients Treated With Bioresorbable Scaffold

NCT03119012 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

25

Enrollment

OTHER

Sponsor class

Stopped cannot use bioabsorbable scaffold

Conditions

Coronary Artery Disease
Stents
Atherosclerosis

Interventions

DRUG: Clopidogrel
DRUG: Ticagrelor
DRUG: Aspirin

Sponsor

Samsung Medical Center